A study to evaluate the efficacy and safety of 3 study drugs in treatment of patients with with any type of eczematous disorderassociated with underlying tinea / yeast infectio
Phase 4
Completed
- Conditions
- Health Condition 1: null- eczematous disorder with underlying tinea/yeast infection
- Registration Number
- CTRI/2012/09/003000
- Lead Sponsor
- Abbott Healthcare Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 54
Inclusion Criteria
•Patients aged 18 years and above diagnosed with any type of eczematous disorder associated presenting clinical features of underlying tinea/yeast infection
•Patients who agree to adhere to the study design
•Patients who give their consent for participation in this study
Exclusion Criteria
•Pregnant or lactating females
•Indications for use of systemic therapy
•Patients sensitive to corticosteroids
•Patients who have immune deficiency, hepatic or renal impairment
•Patients who have been on any therapy within 1 month prior to enrollment in the study
•Patients who are using any other concomitant therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method